Cantor Fitzgerald Maintains Neutral on Aspira Womens Health, Lowers Price Target to $3.3
Portfolio Pulse from Benzinga Newsdesk
Cantor Fitzgerald analyst Ross Osborn has maintained a Neutral rating on Aspira Womens Health (NASDAQ:AWH) and lowered the price target from $4 to $3.3.

April 01, 2024 | 12:27 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Cantor Fitzgerald has maintained a Neutral rating on Aspira Womens Health and reduced the price target from $4 to $3.3.
The adjustment in price target by a notable analyst firm like Cantor Fitzgerald, while maintaining a Neutral rating, suggests a recalibration of expectations without a fundamental change in the company's outlook. This could lead to short-term price adjustments as the market aligns with the new target, but the neutral stance indicates no significant bullish or bearish sentiment.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100